What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q1 2018?

149 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q1 2018. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 72,567,037
Share change: +12,024,824
Total reported value: $2,001,875,074
Put/Call ratio: 90%
Price per share: $27.60
Number of holders: 149
Value change: +$342,791,800
Number of buys: 96
Number of sells: 59

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5.3%	9,622,009	$174,158,000	—	31 Dec 2017	13F
FRANKLIN RESOURCES INC	13F	Company	4.5%	8,195,703	$148,357,000	—	31 Dec 2017	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.9%	7,061,862	$127,820,000	—	31 Dec 2017	13F
BAKER BROS. ADVISORS LP	13F	Company	1.7%	3,060,641	$55,398,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	1.6%	2,977,436	$53,891,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	1.3%	2,417,280	$43,754,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	1.2%	2,229,023	$40,343,000	—	31 Dec 2017	13F
Rubric Capital Management LP	13F	Company	1.2%	2,197,312	$39,771,000	—	31 Dec 2017	13F
Broadfin Capital, LLC	13F	Company	1.1%	2,028,518	$36,716,000	—	31 Dec 2017	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.95%	1,729,657	$31,307,000	—	31 Dec 2017	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.89%	1,629,881	$29,501,000	—	31 Dec 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.87%	1,589,864	$28,777,000	—	31 Dec 2017	13F
Carlson Capital, L.P.	13F	Company	0.82%	1,501,544	$27,178,000	—	31 Dec 2017	13F
HIGHLAND CAPITAL MANAGEMENT LP	13F	Company	0.82%	1,494,175	$27,044,000	—	31 Dec 2017	13F
Alyeska Investment Group, L.P.	13F	Company	0.72%	1,319,945	$23,891,000	—	31 Dec 2017	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.46%	838,117	$15,170,000	—	31 Dec 2017	13F
ORBIMED ADVISORS LLC	13F	Company	0.36%	650,000	$11,765,000	—	31 Dec 2017	13F
CITIGROUP INC	13F	Company	0.35%	637,044	$11,530,000	—	31 Dec 2017	13F
Invesco Ltd.	13F	Company	0.32%	575,265	$10,412,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.3%	542,959	$9,827,000	—	31 Dec 2017	13F
D. E. Shaw & Co., Inc.	13F	Company	0.27%	495,632	$8,971,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.24%	440,862	$7,976,000	—	31 Dec 2017	13F
First Light Asset Management, LLC	13F	Company	0.23%	413,721	$7,488,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	397,456	$7,193,000	—	31 Dec 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.2%	359,155	$6,501,000	—	31 Dec 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.17%	315,173	$5,705,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.16%	285,208	$5,163,000	—	31 Dec 2017	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.14%	259,382	$4,695,000	—	31 Dec 2017	13F
Rock Springs Capital Management LP	13F	Company	0.14%	250,000	$4,525,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	242,934	$4,398,000	—	31 Dec 2017	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.11%	201,977	$3,656,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.11%	200,698	$3,633,000	—	31 Dec 2017	13F
Cormorant Asset Management, LP	13F	Company	0.11%	200,000	$3,620,000	—	31 Dec 2017	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.1%	180,600	$3,269,000	—	31 Dec 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	145,872	$2,640,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.08%	138,676	$2,510,000	—	31 Dec 2017	13F
C WorldWide Group Holding A/S	13F	Company	0.07%	131,600	$2,382,000	—	31 Dec 2017	13F
Fisher Asset Management, LLC	13F	Company	0.07%	121,069	$2,191,000	—	31 Dec 2017	13F
DELTEC ASSET MANAGEMENT LLC	13F	Company	0.06%	117,000	$2,118,000	—	31 Dec 2017	13F
Crestline Management, LP	13F	Company	0.06%	116,290	$2,105,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.06%	112,534	$2,037,000	—	31 Dec 2017	13F
Squarepoint Ops LLC	13F	Company	0.06%	111,584	$2,020,000	—	31 Dec 2017	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	110,900	$2,007,000	—	31 Dec 2017	13F
Allianz Asset Management GmbH	13F	Company	0.06%	109,591	$1,983,000	—	31 Dec 2017	13F
Asymmetry Capital Management, L.P.	13F	Company	0.05%	99,181	$1,795,000	—	31 Dec 2017	13F
Swiss National Bank	13F	Company	0.05%	98,500	$1,783,000	—	31 Dec 2017	13F
B. Riley Wealth Advisors, Inc.	13F	Company	0.05%	91,886	$1,664,000	—	31 Dec 2017	13F
SECOR Capital Advisors, LP	13F	Company	0.05%	90,099	$1,631,000	—	31 Dec 2017	13F
Atika Capital Management LLC	13F	Company	0.05%	90,000	$1,629,000	—	31 Dec 2017	13F
PRIVATE ASSET MANAGEMENT INC	13F	Company	0.05%	86,975	$1,574,000	—	31 Dec 2017	13F

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q1 2018

As of 31 Mar 2018, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 149 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 72,567,037 shares. The largest 10 holders included FMR LLC, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, ArrowMark Colorado Holdings LLC, WELLINGTON MANAGEMENT GROUP LLP, and EAGLE ASSET MANAGEMENT INC. This page lists 149 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

120

Q1 2018 holders

149

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.